⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3984305 | 0.84 | FDPS (0.50) | — | |
| SCHEMBL2351336 | 0.84 | FDPS (0.50) | — | |
| SCHEMBL2346609 | 0.82 | FDPS (0.47) | — | |
| Pyrophosphoric Acid SCHEMBL2420398 | 0.81 | FDPS (0.91) | — | |
| SCHEMBL8533159 | 0.80 | — | — | |
| Pyrophosphoric Acid SCHEMBL3654 | 0.76 | — | — | |
| Pyrophosphoric Acid SCHEMBL292348 | 0.76 | FDPS (1.00) | — | |
| Pyrophosphoric Acid SCHEMBL8851914 | 0.76 | FDPS (1.00) | — | |
| Pyrophosphoric Acid SCHEMBL29634664 | 0.76 | — | — | |
| Pyrophosphoric Acid SCHEMBL28033561 | 0.74 | FDPS (0.77) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 441 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025233518-A1 | CROSSING THE BLOOD BRAIN BARRIER TO TREAT DISEASES OF THE BRAIN | HARBOUR ANTIBODIES BV (NL) | 2025-11-13 | — | — | WO | claimed |
| US-20240277872-A1 | MODIFIED MRNA, MODIFIED NON-CODING RNA, AND USES THEREOF | THE BROAD INSTITUTE, INC. (US) | 2024-08-22 | — | — | US | claimed |
| EP-4337331-A1 | MODIFIED MRNA, MODIFIED NON-CODING RNA, AND USES THEREOF | The Broad Institute Inc. (US) | 2024-03-20 | — | — | EP | claimed |
| US-20230406870-A1 | PROCESS FOR PREPARING DIMERIC PHOSPHAZENE DERIVED BRØNSTED ACIDS | STUDIENGESELLSCHAFT KOHLE GGMBH (DE) | 2023-12-21 | — | — | US | claimed |
| EP-4200308-A1 | PROCESS FOR PREPARING DIMERIC PHOSPHAZENE DERIVED BRØNSTED ACIDS | Studiengesellschaft Kohle gGmbH (DE) | 2023-06-28 | — | — | EP | claimed |
| CN-116348435-A | Process for preparing dimeric phosphazene-derived bronsted acids | 科勒研究非盈利有限责任公司 | 2023-06-27 | — | — | CN | claimed |
| WO-2022241045-A1 | MODIFIED MRNA, MODIFIED NON-CODING RNA, AND USES THEREOF | THE BROAD INSTITUTE, INC. (US) | 2022-11-17 | — | — | WO | claimed |
| WO-2022073803-A1 | PROCESS FOR PREPARING DIMERIC PHOSPHAZENE DERIVED BRØNSTED ACIDS | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2022-04-14 | — | — | WO | claimed |
| US-20210008104-A1 | COMPOSITIONS AND METHODS FOR INHIBITING HIV-1 REVERSE TRANSCRIPTASE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2021-01-14 | — | — | US | claimed |
| EP-3664811-A2 | COMPOSITIONS AND METHODS FOR INHIBITING HIV-1 REVERSE TRANSCRIPTASE | The U.S.A. as represented by the Secretary, Department of Health and Human Services (US) | 2020-06-17 | — | — | EP | claimed |
| EP-0470965-A1 | PREPARATION OF RHENIUM PHOSPHONATE THERAPEUTIC AGENTS. | MALLINCKRODT INC (US) | 1992-02-19 | — | — | EP | claimed |
| WO-1992000758-A1 | METHOD OF PREPARING A RADIOACTIVE RHENIUM COMPLEX SOLUTION | MALLINCKRODT MEDICAL, INC. (US) | 1992-01-23 | — | — | WO | claimed |
| WO-1992000759-A2 | STABILIZED THERAPEUTIC RADIOPHARMACEUTICAL COMPLEXES | MALLINCKRODT MEDICAL, INC. (US) | 1992-01-23 | — | — | WO | claimed |
| US-5021235-A | Preparation of rhenium phosphonate therapeutic agents for bone cancer without purification | MALLINCKRODT, INC. (US) | 1991-06-04 | — | — | US | claimed |
| EP-0250966-B1 | PROCEDURE FOR ISOLATING AND PURIFYING RADIOACTIVE LIGATED RHENIUM PHARMACEUTICALS AND USE THEREOF AND KIT | UNIVERSITY OF CINCINNATI (US) | 1991-02-06 | — | — | EP | claimed |
| WO-1990013530-A1 | PREPARATION OF RHENIUM PHOSPHONATE THERAPEUTIC AGENTS | MALLINCKRODT, INC. (US) | 1990-11-15 | — | — | WO | claimed |
| US-4935222-A | STERILE, PYROGEN-FREE RADIOACTIVE RHENIUM COMPLEX FORMED BY REDUCTION OF PERRHENATE, BONDING TO LIGAND, SEPARATION ON COLUMN | UNIVERSITY OF CINCINNATI (US) | 1990-06-19 | — | — | US | claimed |
| EP-0250966-A1 | Procedure for isolating and purifying radioactive ligated rhenium pharmaceuticals and use thereof and kit | UNIVERSITY OF CINCINNATI (US) | 1988-01-07 | — | — | EP | claimed |
| EP-0043630-B1 | IMPROVED PROCESS FOR THE SILYLATION OF ORGANIC COMPOUNDS WITH 1,1,1-TRIMETHYL-N-(TRIMETHYLSILYL)SILANAMINE BY MEANS OF CATALYSIS WITH CERTAIN NITROGEN CONTAINING COMPOUNDS | GIST-BROCADES N.V. (NL) | 1986-01-08 | — | — | EP | claimed |
| EP-0043630-A2 | Improved process for the silylation of organic compounds with 1,1,1-trimethyl-N-(trimethylsilyl)silanamine by means of catalysis with certain nitrogen containing compounds | GIST-BROCADES N.V. (NL) | 1982-01-13 | — | — | EP | claimed |